News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
595,504 Results
Type
Article (21959)
Company Profile (336)
Press Release (573124)
Multimedia
Podcasts (122)
Webinars (16)
Section
Business (198216)
Career Advice (480)
Deals (30392)
Drug Delivery (62)
Drug Development (72110)
Employer Resources (43)
FDA (12456)
Job Trends (10902)
News (290189)
Policy (22623)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (1320)
Accelerated approval (44)
ADA (40)
Adcomms (16)
Allergies (152)
Alliances (42064)
ALS (218)
Alzheimer's disease (1536)
Antibody-drug conjugate (ADC) (567)
Approvals (13075)
Artificial intelligence (610)
ASCO (275)
Autoimmune disease (367)
Automation (40)
Bankruptcy (312)
Best Places to Work (8687)
BIO (67)
Biologics (9)
BIOSECURE Act (9)
Biosimilars (197)
BioSpace Insights (87)
Biotechnology (236)
Bispecific (1)
Bladder cancer (179)
Brain cancer (68)
Breast cancer (707)
Cancer (5775)
Cardiovascular disease (425)
Career advice (412)
Career pathing (16)
CAR-T (340)
CDC (10)
CDMO (99)
Celiac Disease (1)
Cell therapy (927)
Cervical cancer (48)
Clinical research (64317)
Collaboration (2133)
Commercialization (8)
Company closure (6)
Compensation (1620)
Complete response letters (77)
COVID-19 (1513)
CRISPR (127)
C-suite (1235)
Cystic fibrosis (148)
Data (8244)
Denatured (28)
Depression (166)
Dermatology (101)
Diabetes (521)
Diagnostics (4994)
Digital health (46)
Diversity (6)
Diversity, equity & inclusion (12)
Drug discovery (369)
Drug pricing (64)
Drug shortages (5)
Duchenne muscular dystrophy (334)
Earnings (81449)
Editorial (40)
Employer branding (6)
Employer resources (41)
Events (105474)
Executive appointments (1032)
FDA (16116)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (1)
Friedreich's ataxia (25)
Frontotemporal dementia (35)
Funding (1738)
Gene editing (269)
Generative AI (45)
Gene therapy (752)
GLP-1 (718)
Government (1870)
Grass and pollen (4)
Guidances (340)
Healthcare (12354)
Hematology (152)
HIV (70)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (111)
Immunology and inflammation (294)
Immuno-oncology (113)
Indications (210)
Infectious disease (1787)
Inflammatory bowel disease (208)
Inflation Reduction Act (13)
Influenza (99)
Intellectual property (319)
Interviews (60)
IPO (14544)
IRA (15)
Job creations (2588)
Job search strategy (371)
JPM (44)
Kidney cancer (23)
Labor market (43)
Layoffs (341)
Leadership (17)
Legal (5782)
Licensing (24)
Liver cancer (69)
Longevity (33)
Lung cancer (791)
Lymphoma (415)
Machine learning (47)
Management (13)
Manufacturing (895)
Marketing (12)
MASH (193)
Medical affairs (3)
Medical device (10076)
Medtech (10252)
Mergers & acquisitions (17100)
Metabolic disorders (1292)
mRNA (205)
Multiple sclerosis (164)
Multispecific (1)
NASH (15)
Neurodegenerative disease (460)
Neuropsychiatric disorders (108)
Neuroscience (3123)
Neurotech (1)
NextGen: Class of 2026 (4305)
Non-profit (1669)
Now hiring (47)
Obesity (540)
Opinion (162)
Ovarian cancer (229)
Pain (243)
Pancreatic cancer (335)
Parkinson's disease (384)
Partnered (24)
Patents (614)
Patient advocacy (1)
Patient recruitment (816)
Peanut (56)
People (51117)
Peptides (2)
Pharmaceutical (51)
Pharmacy benefit managers (14)
Phase 1 (21221)
Phase 2 (29037)
Phase 3 (19753)
Pipeline (10166)
Policy (133)
Postmarket research (1904)
Preclinical (9063)
Press Release (52)
Prostate cancer (299)
Psychedelics (77)
Radiopharmaceuticals (356)
Rare diseases (1159)
Real estate (4024)
Recruiting (17)
Regulatory (19941)
Reports (36)
Research institute (1413)
Resumes & cover letters (63)
Rett syndrome (50)
RNA editing (32)
RSV (61)
Schizophrenia (180)
Series A (320)
Series B (232)
Service/supplier (5)
Sickle cell disease (119)
Special edition (22)
Spinal muscular atrophy (146)
Sponsored (23)
Startups (3255)
State (1)
Stomach cancer (8)
Supply chain (77)
Tariffs (20)
The Weekly (92)
Vaccines (622)
Venture capital (112)
Weight loss (283)
Women's health (111)
Worklife (5)
Date
Today (176)
Last 7 days (541)
Last 30 days (2032)
Last 365 days (26344)
2026 (18340)
2025 (26215)
2024 (30560)
2023 (34499)
2022 (43933)
2021 (46482)
2020 (41799)
2019 (30746)
2018 (23177)
2017 (24748)
2016 (23275)
2015 (29464)
2014 (25389)
2013 (21249)
2012 (23054)
2011 (23223)
2010 (22817)
Location
Africa (357)
Alabama (95)
Alaska (3)
Arizona (351)
Arkansas (14)
Asia (29803)
Australia (4656)
California (14240)
Canada (3843)
China (1398)
Colorado (574)
Connecticut (554)
Delaware (381)
Europe (56760)
Florida (2059)
Georgia (427)
Hawaii (4)
Idaho (48)
Illinois (974)
India (96)
Indiana (465)
Iowa (19)
Japan (574)
Kansas (125)
Kentucky (40)
Louisiana (44)
Maine (38)
Maryland (1493)
Massachusetts (10297)
Michigan (331)
Minnesota (649)
Mississippi (5)
Missouri (100)
Montana (32)
Nebraska (14)
Nevada (138)
New Hampshire (76)
New Jersey (3306)
New Mexico (19)
New York (3487)
North Carolina (1764)
North Dakota (9)
Northern California (7304)
Ohio (362)
Oklahoma (16)
Oregon (38)
Pennsylvania (2747)
Puerto Rico (27)
Rhode Island (42)
South America (546)
South Carolina (79)
South Dakota (1)
Southern California (5680)
Tennessee (157)
Texas (2284)
United States (48136)
Utah (417)
Vermont (1)
Virginia (257)
Washington D.C. (54)
Washington State (1173)
West Virginia (2)
Wisconsin (122)
Wyoming (1)
595,504 Results for "argos therapeutics inc formerly merix bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment
Novartis and Argo Biopharma go back to January 2024, when the pharma first bet up to $4.165 billion across two RNAi agreements targeting cardiovascular diseases.
September 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Mighty Therapeutics, Formerly Stealth BioTherapeutics, Announces New Name Honoring the Mitochondrial Disease Community
June 16, 2026
·
6 min read
Press Releases
argenx Completes Acquisition of Forte Biosciences, Inc.
August 27, 2026
·
6 min read
Press Releases
La Jolla Labs Inc., Unravel Biosciences Inc., and Ulm University Announce Strategic Collaboration to Advance AI-Driven Therapeutics for ALS
July 16, 2026
·
1 min read
Press Releases
Allotera Therapeutics (Formerly Wugen) Closes $35 Million Financing to Advance Off-the-Shelf CAR-T Therapies for T-Cell Cancers
July 8, 2026
·
5 min read
Press Releases
Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
August 4, 2026
·
14 min read
Press Releases
Ensysce Biosciences to Showcase “A New Era in Pain Therapeutics” at PAINWeek 2026 Symposium
August 20, 2026
·
6 min read
Press Releases
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
September 1, 2026
·
1 min read
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
The star of the takeover is Forte Biosciences’ investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease.
July 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics
May 18, 2026
·
10 min read
1 of 59,551
Next
